SEARCH

SEARCH BY CITATION

References

  • 1
    Adoni T, Lino AM, Marchiori PE, Kok F, Callegaro D (2008) Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica. Arq Neuropsiquiatr 66(2b):295297.
  • 2
    Alvarenga MP, Alvarenga RM, Santos AM, Thuler LC (2012) Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis. J Spinal Cord Med 35:251255.
  • 3
    Amiry-Moghaddam M, Frydenlund DS, Ottersen OP (2004) Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 129:9991010.
  • 4
    Apiwattanakul M, McKeon A, Fryer JP, Hinson SR, Pittock SJ, Lennon VA (2009) AQP4-IgG immunoprecipitation assay optimization. Clin Chem 55:592594.
  • 5
    Apiwattanakul M, Asawavichienjinda T, Pulkes T, Tantirittisak T, Hemachudha T, Horta ES et al (2012) Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients. J Neurol Sci 320:118120.
  • 6
    Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A et al (2008) Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 70:344352.
  • 7
    Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C et al (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617629.
  • 8
    Bergamaschi R (2003) Importance of cerebrospinal fluid examination in differential diagnosis of Devic's neuromyelitis optica by multiple sclerosis. Neurol Sci 24:9596.
  • 9
    Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, Tavazzi E, Piccolo G et al (2004) Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 10:24.
  • 10
    Bizzoco E, Lolli F, Repice AM, Hakiki B, Falcini M, Barilaro A et al (2009) Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 256:18911898.
  • 11
    Bonnan M, Brasme H, Diaby MM, Vlaicu M, Le Guern V, Zuber M (2009) [Severe bouts of neuromyelitis optica: dramatic improvement after plasma exchanges.]. Rev Neurol (Paris) 165:479481.
  • 12
    Chan KH, Kwan JS, Ho PW, Ho JW, Chu AC, Ramsden DB (2010) Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays. J Neuroinflammation 7:50.
  • 13
    Chen T, Hedman L, Mattila PS, Jartti L, Jartti T, Ruuskanen O et al (2012) Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays. PLoS ONE 7:e42376.
  • 14
    Collongues N, Marignier R, Zephir H, Papeix C, Blanc F, Ritleng C et al (2010) Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 74:736742.
  • 15
    Crane JM, Bennett JL, Verkman AS (2009) Live cell analysis of aquaporin-4 M1/M23 interactions and regulated orthogonal array assembly in glial cells. J Biol Chem 284:3585035860.
  • 16
    Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS (2011) Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem 286:1651616524.
  • 17
    Cree BA, Goodin DS, Hauser SL (2002) Neuromyelitis optica. Semin Neurol 22:105122.
  • 18
    Dale GL, Gaddy P, Pikul FJ (1994) Antibodies against biotinylated proteins are present in normal human serum. J Lab Clin Med 123:365371.
  • 19
    De Vidi I, Boursier G, Delouche N, Portales P, Cadars E, Bouthier M et al (2011) Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol 138:239246.
  • 20
    Deeks JJ, Altman DG (2004) Diagnostic tests 4: likelihood ratios. BMJ 329:168169.
  • 21
    Dellavance A, Alvarenga RR, Rodrigues SH, Kok F, de Souza AW, Andrade LE (2012) Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases. Eur J Neurol 19:248252.
  • 22
    Dubois-Galopin F, Beauvillain C, Dubois D, Pillet A, Renier G, Jeannin P et al (2007) New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies. Ann Rheum Dis 66:11211122.
  • 23
    Ducray F, Roos-Weil R, Garcia PY, Slesari J, Heinzlef O, Chatelain D et al (2007) Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 78:325327.
  • 24
    Etemadifar M, Abtahi MA, Razmjoo H, Abtahi SH, Dehghani AR, Abtahi ZA et al (2012) Anti-aquaporin-4 IgG in patients presenting with unilateral optic neuritis: a cohort study. Int J Prev Med 3:612615.
  • 25
    Etemadifar M, Mollabashi M, Chitsaz A, Behnamfar O, Bahrami E, Minagar A, Maghzi AH (2012) Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis. Clin Neurol Neurosurg 114:1720.
  • 26
    Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F et al (2009) Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler 15:11531163.
  • 27
    Fujihara K (2012) Comment: sensitivity and clinical relevance of available anti-aquaporin-4 antibody assays. Neurology 78:669.
  • 28
    Furman CS, Gorelick-Feldman DA, Davidson KG, Yasumura T, Neely JD, Agre P, Rash JE (2003) Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A 100:1360913614.
  • 29
    Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 251:4752.
  • 30
    Graham DA, Foster JC, Mawhinney KA, Elvander M, Adair BM, Merza M (1999) Detection of IgM responses to bovine respiratory syncytial virus by indirect ELISA following experimental infection and reinfection of calves: abolition of false positive and false negative results by pre-treatment of sera with protein-G agarose. Vet Immunol Immunopathol 71:4151.
  • 31
    Granieri L, Marnetto F, Valentino P, Frau J, Patanella AK, Nytrova P et al (2012) Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. PLoS ONE 7:e38896.
  • 32
    Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y et al (2008) Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 196:181187.
  • 33
    Heerlein K, Jarius S, Jacobi C, Rohde S, Storch-Hagenlocher B, Wildemann B (2009) Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J Neurol Sci 276:184186.
  • 34
    Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA (2007) Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69:22212231.
  • 35
    Hiroaki Y, Tani K, Kamegawa A, Gyobu N, Nishikawa K, Suzuki H et al (2006) Implications of the aquaporin-4 structure on array formation and cell adhesion. J Mol Biol 355:628639.
  • 36
    Ho JD, Yeh R, Sandstrom A, Chorny I, Harries WE, Robbins RA et al (2009) Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance. Proc Natl Acad Sci U S A 106:74377442.
  • 37
    Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, Lennon VA (2013) Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun 40:2127.
  • 38
    Isobe N, Yonekawa T, Matsushita T, Kawano Y, Masaki K, Yoshimura S et al (2012) Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica. Mult Scler 18:15411551.
  • 39
    Ito S (2009) Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 73:1604. author reply -5.
  • 40
    Jacob S, Zarei M, Kenton A, Allroggen H (2005) Gluten sensitivity and neuromyelitis optica: two case reports. J Neurol Neurosurg Psychiatry 76:10281030.
  • 41
    Jankowski M, Gut W, Imbs D, Switalski L (1979) Study of interaction between IgG and IgM antibodies against rubella virus by the immunofluorescence method. Acta Microbiol Pol 28:6369.
  • 42
    Jarius S, Wildemann B (2007) [Neuromyelitis optica.]. Nervenarzt 78:13651377.
  • 43
    Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383392.
  • 44
    Jarius S, Wildemann B (2011) An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler 17:13841386.
  • 45
    Jarius S, Wildemann B (2011) Effect of storage conditions and freeze/thaw cycles on aquaporin-4 antibody (NMO-IgG) serum levels. Clin Chem Lab Med 49:21212122.
  • 46
    Jarius S, Wildemann B (2012) The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol 259:13541357.
  • 47
    Jarius S, Wildemann B (2012) An early British case of neuromyelitis optica (1850). BMJ 345:e6430.
  • 48
    Jarius S, Wildemann B (2012) “Noteomielite” accompanied by acute amaurosis (1844). An early case of neuromyelitis optica. J Neurol Sci 313:182184.
  • 49
    Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflammation 10:8.
  • 50
    Jarius S, Wildemann B (2013) On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol 260:100104.
  • 51
    Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J et al (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68:10761077.
  • 52
    Jarius S, Paul F, Franciotta D, Aktas O, Hohlfeld R, Zipp F, Vincent A (2007) Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status. Nat Clin Pract Neurol 3:E1.
  • 53
    Jarius S, Paul F, Martins da Silva A, Leite MI, Waters P, Littleton E et al (2007) Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis. Mult Scler 13(Suppl 2):P534.
  • 54
    Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131(Pt 11):30723080.
  • 55
    Jarius S, Franciotta D, Bergamaschi R, Rauer S, Wandinger KP, Petereit HF et al (2008) Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 79:11341136.
  • 56
    Jarius S, Jacob S, Waters P, Jacob A, Littleton E, Vincent A (2008) Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4. J Neurol Neurosurg Psychiatry 79:1084.
  • 57
    Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202214.
  • 58
    Jarius S, Eichhorn P, Jacobi C, Wildemann B, Wick M, Voltz R (2009) The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity? J Neurol Sci 280:98100.
  • 59
    Jarius S, Franciotta D, Bergamaschi R, Wildemann B, Wandinger KP (2010) Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med 48:659663.
  • 60
    Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS et al (2010) Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 7:52.
  • 61
    Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298:158162.
  • 62
    Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291:5256.
  • 63
    Jarius S, Warth A, Wandinger KP, Schnabel PA, Hoffmann H, Wildemann B, Muley T (2010) Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients. Neurol Sci 31:871872.
  • 64
    Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D et al (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17:10671073.
  • 65
    Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R et al (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 306:8290.
  • 66
    Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K et al (2012) Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci 320:3237.
  • 67
    Jarius S, Paul F, Franciotta D, de Seze J, Munch C, Salvetti M et al (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler 18:11351143.
  • 68
    Jarius S, Paul F, Ruprecht K, Wildemann B (2012) Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol 259:27432745.
  • 69
    Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 9:14.
  • 70
    Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B (2012) Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 114:331335.
  • 71
    Jarius S, Lauda F, Wildemann B, Tumani H (2013) Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica. J Neurol 260:663664.
  • 72
    Kalluri SR, Srivastava R, Cepok S, Menge T, Cree B, Berthele A, Hemmer B (2009) A novel bio-assay to determine and characterize the antibodies to aquaporin-4. Neurology 72(Suppl 3):A189.
  • 73
    Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL et al (2010) Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol 67:12011208.
  • 74
    Kampylafka EI, Routsias JG, Alexopoulos H, Dalakas MC, Moutsopoulos HM, Tzioufas AG (2011) Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes. J Autoimmun 36:221227.
  • 75
    Kang ES, Min JH, Lee KH, Kim BJ (2012) Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder. Ann Lab Med 32:331338.
  • 76
    Katsumata Y, Kawachi I, Kawaguchi Y, Gono T, Ichida H, Hara M, Yamanaka H (2012) Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases. Mod Rheumatol 22:676684.
  • 77
    Kay CS, Scola RH, Lorenzoni PJ, Jarius S, Arruda WO, Werneck LC (2008) NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 275:148150.
  • 78
    Ketelslegers IA, Modderman PW, Vennegoor A, Killestein J, Hamann D, Hintzen RQ (2011) Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients. Mult Scler 17:15271530.
  • 79
    Kim JE, Kim SM, Ahn SW, Lim BC, Chae JH, Hong YH et al (2011) Brain abnormalities in neuromyelitis optica. J Neurol Sci 302:4348.
  • 80
    Kim SH, Kim W, Huh SY, Lee KY, Jung IJ, Kim HJ (2013) Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol 9:3642.
  • 81
    Kim SM, Waters P, Woodhall M, Kim JY, Kim JE, Yang JW et al (2013) Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Mult Scler 19:10601067.
  • 82
    Kim W, Lee JE, Li XF, Kim SH, Han BG, Lee BI et al (2012) Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4. Mult Scler 18:578586.
  • 83
    Kim YJ, Jung SW, Kim Y, Park YJ, Han K, Oh EJ (2012) Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA. J Clin Lab Anal 26:184189.
  • 84
    Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y et al (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40:569574.
  • 85
    Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:12731277.
  • 86
    Klawiter EC, Alvarez E 3rd, Xu J, Paciorkowski AR, Zhu L, Parks BJ et al (2009) NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 72:11011103.
  • 87
    Kleiter I, Hellwig K, Berthele A, Kumpfel T, Linker RA, Hartung HP et al (2012) Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 69:239245.
  • 88
    Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP et al (2008) IgG1 antibodies to acetylcholine receptors in “seronegative” myasthenia gravis. Brain 131(Pt 7):19401952.
  • 89
    Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D et al (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78:16011607.
  • 90
    Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:21062112.
  • 91
    Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473477.
  • 92
    Long Y, Hu X, Peng F, Lu Z, Wang Y, Yang Y, Qiu W (2012) Neuromyelitis optica immunoglobulin G in Chinese patients detected by immunofluorescence assay on a monkey brain substrate. Neuroimmunomodulation 19:2024.
  • 93
    Long Y, Lu Z, Hu X (2012) Serum-positive and -negative AQP4 antibody NMO in Chinese patients. Can J Neurol Sci 39:232235.
  • 94
    Long Y, Qiu W, Hu X, Peng F, Lu Z, Wang Y, Yang Y (2012) Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders. Clin Neurol Neurosurg 114:11311134.
  • 95
    Long Y, Qiu W, Lu Z, Bao J, Wu A, Wang Y et al (2012) Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing chinese patients with neuromyelitis optica. Neuroimmunomodulation 19:96102.
  • 96
    Long Y, Qiu W, Lu Z, Peng F, Hu X (2013) Clinical features of Chinese patients with multiple sclerosis with aquaporin-4 antibodies in cerebrospinal fluid but not serum. J Clin Neurosci 20:233237.
  • 97
    Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV (2008) Spectrum of pediatric neuromyelitis optica. Pediatrics 122:e1039e1047.
  • 98
    Lourenco EV, Roque-Barreira MC (2010) Immunoenzymatic quantitative analysis of antigens expressed on the cell surface (cell-ELISA). Methods Mol Biol 588:301309.
  • 99
    Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F et al (2010) Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS ONE 5:e10455.
  • 100
    Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184.
  • 101
    Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA et al (2009) Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72:712717.
  • 102
    Marignier R, De Seze J, Vukusic S, Durand-Dubief F, Zephir H, Vermersch P et al (2008) NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler 14:440445.
  • 103
    Marnetto F, Granieri L, Sala A, Frau J, Patanella AK, Gilli F et al (2009) Validation of a multi-parametric immunofluorescence assay for the detection of anti-AQP4 antibodies in the diagnosis of neuromyelitis optica. Mult Scler 15:P154.
  • 104
    Marnetto F, Hellias B, Granieri L, Frau J, Patanella AK, Nytrova P et al (2009) Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. J Neuroimmunol 217:7479.
  • 105
    Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70:21972200.
  • 106
    Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T et al (2007) Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130(Pt 5):12061223.
  • 107
    Matsushita T, Isobe N, Matsuoka T, Shi N, Kawano Y, Wu XM et al (2009) Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 15:834847.
  • 108
    Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H et al (2010) Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J Neurol Sci 291:3743.
  • 109
    McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121127.
  • 110
    McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ et al (2009) Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 66:11341138.
  • 111
    McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M et al (2008) CNS aquaporin-4 autoimmunity in children. Neurology 71:93100.
  • 112
    McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N et al (2009) Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39:8790.
  • 113
    Mealy MA, Wingerchuk DM, Greenberg BM, Levy M (2012) Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol 69:11761180.
  • 114
    Meurman OH, Ziola BR (1978) IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol 31:483487.
  • 115
    Mori M, Kawaguchi N, Uzawa A, Nemoto Y, Masuda S, Kuwabara S (2012) Seroconversion of anti-aquaporin-4 antibody in NMO spectrum disorder: a case report. J Neurol 259:980981.
  • 116
    Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M et al (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77:10731075.
  • 117
    Nakashima I, Takahashi T, Cree BA, Kim HJ, Suzuki C, Genain CP et al (2011) Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels. J Clin Neurosci 18:997998.
  • 118
    Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M et al (2009) Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 57:13631373.
  • 119
    Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N et al (2009) A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72:19601961.
  • 120
    Palace J, Leite MI, Nairne A, Vincent A (2010) Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 67:10161017.
  • 121
    Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B et al (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13:256259.
  • 122
    Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180185.
  • 123
    Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H et al (2007) Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. Plos Med 4:e133.
  • 124
    Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81:109111.
  • 125
    Pisani F, Mastrototaro M, Rossi A, Nicchia GP, Tortorella C, Ruggieri M et al (2011) Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem 286:92169224.
  • 126
    Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390396.
  • 127
    Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964968.
  • 128
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:7883.
  • 129
    Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840846.
  • 130
    Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292302.
  • 131
    Rossi A, Pisani F, Nicchia GP, Svelto M, Frigeri A (2010) Evidences for a leaky scanning mechanism for the synthesis of the shorter M23 protein isoform of aquaporin-4: implication in orthogonal array formation and neuromyelitis optica antibody interaction. J Biol Chem 285:45624569.
  • 132
    Rostasy K, Mader S, Hennes E, Schanda K, Gredler V, Guenther A et al (2013) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19:10521059.
  • 133
    Rostasy K, Mader S, Schanda K, Huppke P, Gartner J, Kraus V et al (2012) Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 69:752756.
  • 134
    Sabater L, Giralt A, Boronat A, Hankiewicz K, Blanco Y, Llufriu S et al (2009) Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J Neuroimmunol 215:3135.
  • 135
    Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F (2007) Revised diagnostic criteria for neuromyelitis optica (NMO): application in a series of suspected patients. J Neurol 254:12331237.
  • 136
    Salonen EM, Vaheri A, Suni J, Wager O (1980) Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis 142:250255.
  • 137
    Scott TF, Kassab SL, Pittock SJ (2006) Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 63:13981400.
  • 138
    Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H et al (2010) IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 75:14231427.
  • 139
    Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S et al (2008) Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255:305307.
  • 140
    Smith CH, Waubant E, Langer-Gould A (2009) Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. J Neuroophthalmol 29:104106.
  • 141
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M et al (2006) Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 210:307313.
  • 142
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130(Pt 5):12351243.
  • 143
    Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K et al (2008) Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 79:10751078.
  • 144
    Tanaka K, Tani T, Tanaka M, Saida T, Idezuka J, Yamazaki M et al (2007) Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 13:850855.
  • 145
    Tanaka M, Tanaka K, Komori M (2009) Interferon-beta(1b) treatment in neuromyelitis optica. Eur Neurol 62:167170.
  • 146
    Tani T, Sakimura K, Tsujita M, Nakada T, Tanaka M, Nishizawa M, Tanaka K (2009) Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica. J Neuroimmunol 211:110113.
  • 147
    Trebst C, Berthele A, Jarius S, Kumpfel T, Schippling S, Wildemann B, Wilke C (2011) [Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group]. Nervenarzt 82:768777.
  • 148
    Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S (2010) Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol 17:672676.
  • 149
    Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S et al (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 62:11981200.
  • 150
    Warabi Y, Matsumoto Y, Hayashi H (2007) Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 252:5761.
  • 151
    Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B et al (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65:913919.
  • 152
    Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A et al (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78:665671. discussion 9.
  • 153
    Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA (2006) OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5:110111.
  • 154
    Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566569.
  • 155
    Wildemann B, Jarius S, Paul F (2013) [Neuromyelitis optica.]. Nervenarzt 84:436441.
  • 156
    Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:11071114.
  • 157
    Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:14851489.
  • 158
    Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805815.
  • 159
    Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 20:9498.
  • 160
    Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S et al (2013) Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 84:2934.
  • 161
    Zavada J, Nytrova P, Wandinger KP, Jarius S, Svobodova R, Probst C et al (2013) Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int 33:259263.
  • 162
    Zhang X, Shu H, Zhang F, Tian X, Dong Y (2007) Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 66:530532.
  • 163
    Zhong XN, Wang HH, Bao J, Li R, Long YM, Lu ZQ et al (2012) Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica. Chin Med J (Engl) 125:270274.